Resmed Inc
ASX:RMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
ASX:RMD
|
US |
|
A
|
Alujain Corp
SAU:2170
|
SA |
|
N
|
NICE Holdings Co Ltd
KRX:034310
|
KR |
|
Urbas Grupo Financiero SA
MAD:UBS
|
ES |
|
B
|
Bactiquant A/S
CSE:BACTIQ
|
DK |
|
Antin Infrastructure Partners SAS
PAR:ANTIN
|
FR |
|
F
|
Fonix Mobile PLC
F:FOS
|
UK |
Wall Street
Price Targets
RMD Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for
RMD
is 42.17 AUD
with a low forecast of 32.28 AUD and a high forecast of 50.34 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RMD's stock price target?
Price Target
42.17
AUD
According to Wall Street analysts, the average 1-year price target for
RMD
is 42.17 AUD
with a low forecast of 32.28 AUD and a high forecast of 50.34 AUD.
What is Resmed Inc's Revenue forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Resmed Inc's revenue is
11%.
The projected
CAGR
for the next 3 years is
8%.
What is Resmed Inc's Operating Income forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Resmed Inc's operating income is
14%.
The projected
CAGR
for the next 3 years is
12%.
What is Resmed Inc's Net Income forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Resmed Inc's net income is
14%.
The projected
CAGR
for the next 3 years is
11%.
